PAUL J SCHECHTER, M.D.
Osteopathic Medicine at Dedham St, Dover, MA

2004011, Jun 10, 2004

Oct 22, 2003

10/690710

Scott Gillis - Concord MA, US
Paul Schechter - Dover MA, US
Robert Demling - Natick MA, US

A61K031/555, A61K031/28, A61K033/24

514/184000, 424/617000, 514/492000

Prophylactic treatment methods are disclosed. The methods can include contacting an object and/or an area of a subject with a metal-containing material to reduce the occurrence of a condition at the same area or a different area of the subject. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm metal-containing material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, an anti-proliferative material, an MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.

7255881, Aug 14, 2007

Oct 22, 2003

10/690774

Scott H. Gillis - Concord MA, US
Paul Schechter - Dover MA, US
James Alexander Robert Stiles - Toronto, CA

Nucryst Pharmaceuticals Corp. - Fort Saskatchewan, Alberta

A61K 9/02, A61K 9/14, A61K 31/28, A61K 31/282, A61K 33/00, A61K 33/24, A61K 33/38, A61K 33/42

424618, 424604, 424619, 424646, 424649, 424430, 424433, 424436, 424489, 514492, 514495, 514951, 514966, 514967, 514968

Metal-containing materials, as well as their preparation and use are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.

2004019, Sep 30, 2004

Oct 22, 2003

10/690715

Robert Burrell - Alberta, CA
John Wright - San Antonio TX, US
Kan Lam - San Antonio TX, US
Hua Yin - Alberta, CA
Antony Naylor - Ontario, CA
Peter Moxham - Alberta, CA
Scott Gillis - Concord MA, US
Paul Schechter - Dover MA, US
James Robert Stiles - Toronto, CA

A61K033/38

424/618000

Compositions and methods of metal-containing materials of metal-containing materials are disclosed. The metal-containing material can be, for example, an antimicrobial material, an anti-biofilm material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, anti-proliferative, MMP modulating material, an atomically disordered, crystalline material, and/or a nanocrystalline material. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.

7078060, Jul 18, 2006

Feb 12, 2003

10/364983

Robert E. Burrell - Alberta, CA
John B. Wright - San Antonio TX, US
Kan Lam - San Antonio TX, US
Hua Qing Yin - Alberta, CA
Antony G. Naylor - Alberta, CA
Peter H. Moxham - Alberta, CA
Scott H. Gillis - Concord MA, US
Paul Schechter - Dover MA, US

Nucryst Pharmaceuticals Corp. - Fort Saskatchewan

A61K 33/38, A61K 31/28, A61K 9/127, A61K 9/133, A61K 9/52, A61P 17/00, A61P 17/02

424618, 424450, 424489, 424619, 514184, 514275, 514498, 514772, 514858, 514859, 514865, 514886, 514887, 514936, 514937, 514938, 514946, 514964

Solutions and aerosols of metal-containing compounds are disclosed. Methods of preparing and using the solutions and aerosols, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.

2005013, Jun 23, 2005

Nov 29, 2004

10/998499

Scott Gillis - Concord MA, US
Paul Schechter - Dover MA, US
Robert Burrell - Alberta, CA

A61K033/38, A61K033/24

424618000, 424649000

Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.

6989157, Jan 24, 2006

Oct 22, 2002

10/277298

Scott H. Gillis - Concord MA, US
Paul Schechter - Dover MA, US
Robert E. Burrell - Alberta, CA

Nucryst Pharmaceuticals Corp. - Fort Saskatchewan

A61K 9/14, A61K 31/28, A61K 31/282, A61K 33/24, A61K 33/38

424618, 424400, 424489, 424490, 424617, 424619, 424646, 424649, 514492, 514495, 514849, 514853, 514888, 514924, 514951, 514952, 514958

Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.

2003018, Sep 25, 2003

Oct 22, 2002

10/277673

Robert Burrell - Alberta, CA
Scott Gillis - Concord MA, US
Paul Schechter - Dover MA, US
John Wright - San Antonio TX, US
Kan Lam - San Antonio TX, US
Hua Yin - Alberta, CA
Antony Naylor - Alberta, CA
Peter Moxham - Alberta, CA

A61K033/38, A61K033/26, A61K033/24

424/618000, 424/646000, 424/649000

Solutions and aerosols of metal-containing compounds are disclosed. Methods of preparing and using the solutions and aerosols, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.

6866871, Mar 15, 2005

Oct 22, 2002

10/277298

Scott H. Gillis - Concord MA, US
Paul Schechter - Dover MA, US
Robert E. Burrell - Alberta, CA

Nucryst Pharmaceuticals Corp. - Alberta

A61K009/14, A61K031/28, A61K031/282, A61K033/24, A61K033/38

424618, 424400, 424489, 424490, 424617, 424619, 424646, 424649, 514492, 514495, 514849, 514853, 514888, 514924, 514951, 514952, 514958

Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.

2006011, Jun 1, 2006

Oct 14, 2005

11/250516

Scott Gillis - Concord MA, US
Paul Schechter - Dover MA, US

A61K 33/24, A61K 33/38

424618000, 424649000, 977906000

Treatment of bladder conditions is disclosed

2006024, Oct 26, 2006

Mar 29, 2006

11/391761

Scott Gillis - Concord MA, US
Steve Chartier - Bedford NH, US
Wen Chen - Woburn MA, US
Cheng Lu - Newton MA, US
Paul Schechter - Dover MA, US

A61K 33/38, A61F 2/00

424423000, 424618000, 977906000

Biocompatible articles and related methods are disclosed.